[1]缪素红,张 静.输血前不规则抗体筛查结果分析[J].医学信息,2021,34(21):150-152.[doi:10.3969/j.issn.1006-1959.2021.21.042]
　MIAO Su-hong,ZHANG Jing.Analysis of Irregular Antibody Screening Results Before Blood Transfusion[J].Medical Information,2021,34(21):150-152.[doi:10.3969/j.issn.1006-1959.2021.21.042]
点击复制

输血前不规则抗体筛查结果分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年21期
页码:
150-152
栏目:
调查分析
出版日期:
2021-11-01

文章信息/Info

Title:
Analysis of Irregular Antibody Screening Results Before Blood Transfusion
文章编号:
1006-1959（2021）21-0150-03
作者:
缪素红; 张 静
（南京市江宁中医院输血科，江苏 南京 211100）
Author(s):
MIAO Su-hong; ZHANG Jing
(Department of Blood Transfusion,Jiangning Hospital of Traditional Chinese Medicine,Nanjing 211100,Jiangsu,China)
关键词:
输血; 不规则抗体; 免疫溶血性输血反应
Keywords:
Blood transfusion; Irregular antibodies; Immune hemolytic transfusion reaction
分类号:
R457.1
DOI:
10.3969/j.issn.1006-1959.2021.21.042
文献标志码:
A
摘要:
目的 分析输血前不规则抗体筛查结果。方法 选取2018年1月-2021年3月南京市江宁中医院共6528例输血前进行不规则抗体筛查的患者作为研究对象，分析不规则抗体筛查在免疫溶血性输血反应中的预防效果。结果 6528例输血前进行不规则抗体筛查的患者中不规则抗体筛查阳性70例，阳性率为1.07%；不同性别、妊娠史、输血史、肿瘤、血液疾病、消化道疾病间阳性率比较，差异有统计学意义（P＜0.05）。70例不规则抗体筛查阳性中，Rh系统抗体阳性55例，占比78.57%；MMS系统抗体阳性9例，占比12.86%；Lewis系统抗体阳性6例，占比8.57%。经术前配血检测后，60例患者有相符合血型的血液输注，未发生免疫溶血性输血反应；8例患者未发现合适配血者，取消配血；2例发生溶血性贫血，均是由于自身抗体导致筛查结果为假阳性，输注洗涤红细胞，未出现输血不良反应。共发生4例免疫溶血性输血反应，发生率为0.06%。结论 妊娠、多次输血、肿瘤疾病、血液疾病及消化道疾病是导致不规则抗体发生的重要因素，而输血前不规则抗体筛查对免疫溶血性输血具有良好的预防作用，有利于提高输血的安全性。
Abstract:
Objective To analyze the results of irregular antibody screening before blood transfusion.Methods A total of 6528 patients who underwent irregular antibody screening before blood transfusion in Jiangning Hospital of Traditional Chinese Medicine from January 2018 to March 2021 were selected as subjects. The preventive effect of irregular antibody screening in immune hemolytic transfusion reaction was analyzed.Results Among 6528 patients with irregular antibody screening before blood transfusion, 70 cases were positive for irregular antibody screening, and the positive rate was 1.07%. There were statistically significant differences in the positive rates of gender, pregnancy history, blood transfusion history, tumor, blood disease and digestive tract disease (P<0.05). Among 70 cases of irregular antibody screening positive, 55 cases were Rh system antibody positive, accounting for 78.57%; 9 cases were MMS system antibody positive, accounting for 12.86%; 6 cases were Lewis system antibody positive, accounting for 8.57%. After preoperative blood test, 60 patients had blood transfusion consistent with blood type, and no immune hemolytic transfusion reaction occurred; 8 patients did not find suitable blood, cancel the blood; 2 cases of hemolytic anemia were due to autoantibodies leading to false positive screening results, transfusion of washed red blood cells, no adverse transfusion reactions. There were 4 cases of immune hemolytic transfusion reaction, the incidence was 0.06%.Conclusion Pregnancy, multiple blood transfusions, tumor diseases, blood diseases and digestive tract diseases are important factors leading to irregular antibodies, and irregular antibody screening before blood transfusion has a good preventive effect on immune hemolytic transfusion, which is beneficial to improve the safety of blood transfusion.

参考文献/References:

[1]詹廷西,王静,徐丹丹,等.输血前患者不规则抗体筛查及鉴定的临床意义探讨[J].中国免疫学杂志,2021,37(3):335-338,345. [2]徐春柳,蔡兴权,陈德娟,等.海南地中海贫血输血患儿不规则抗体检测[J].中国实验血液学杂志,2021,29(1):243-247. [3]van Gammeren AJ,van den Bos AG,Som N,et al.A national Transfusion Register of Irregular Antibodies and Cross (X)-match Problems: TRIX, a 10-year analysis[J].Transfusion,2019,59(8):2559-2566.[4]刘金莲,李丽兰,刘学军,等.南宁地区疑难输血患者红细胞不规则抗体的分析[J].中国输血杂志,2020,33(1):60-63.[5]Ahn A,Hwang SH.Acute Hemolytic Transfusion Reaction Due to the "Anti-E" Rhesus Antibody in a Patient with Crohn’s Disease[J].Clin Lab,2019,65(9):31532084[6]郭萍莉.无偿献血者不规则抗体分布及输血安全分析[J].山西医药杂志,2020,48(11):1333-1335. [7]Makroo RN,Rajput S,Agarwal S,et al.Prevalence of irregular red cell antibody in healthy blood donors attending a tertiary care hospital in North India[J].Asian J Transfus Sci,2018,12(1):17-20.[8]郭刚,赵妮,王丽萍.输血患者1600例输血前不规则抗体检测结果分析[J].中国临床研究,2020,33(4):521-523. [9]王丽,刘颖,李文娟,等.8775例拟输血患者不规则抗体检出情况及危险因素分析[J].临床输血与检验,2020,22(5):480-483. [10]陈丽娟,杨延敏.不规则抗体筛查阳性结果分析及输血策略[J].检验医学与临床,2019,16(12):1773-1775. [11]Liu J,Wang S,Sha D,et al.Effects of cooperative blood transfusion and homologous blood transfusion on the production of red blood cell irregular antibodies in obstetric patients[J].Exp Ther Med,2019,17(5):3477-3482.[12]梁宝华,黃燕芬,郑博金,等.输血前不规则抗体筛查在避免免疫溶血性输血反应中的预防效果分析[J].检验医学与临床,2019,16(13):1880-1882,1885. [13]原霞,陈慧园,刘波,等.不规则抗体筛查在临床患者输血过程中的应用效果探讨[J].检验医学与临床,2019,16(20):3029-3030.[14]Wang MQ,Gao JJ,Xie RW,et al.Analysis of Irregular Antibody Production in Severe β-Thalassemia Children with long-term Blood Transtusion and Its Correlation with RH Gene and Anemia Gene Mutation Site[J].Journal of Experimental Hematology,2017,25(6):1756-1760.

相似文献/References:

[1]张炳勇,彭 红.血栓弹力图对围术期患者输血的临床指导价值[J].医学信息,2018,31(02):80.[doi:10.3969/j.issn.1006-1959.2018.02.027]
　ZHANG Bing-yong,PENG Hong.Clinical Guiding Value of Thrombelastography in Patients with Perioperative Blood Transfusion[J].Medical Information,2018,31(21):80.[doi:10.3969/j.issn.1006-1959.2018.02.027]
[2]张林.围术期输血对胃癌根治术患者预后及免疫的影响[J].医学信息,2018,31(01):94.[doi:10.3969/j.issn.1006-1959.2018.01.033]
　ZHANG Lin.Effect of Perioperative Blood Transfusion on Prognosis and Immunity of Patients with Radical Gastrectomy[J].Medical Information,2018,31(21):94.[doi:10.3969/j.issn.1006-1959.2018.01.033]
[3]王尉霖,张 健.氨甲环酸在髋膝关节置换中的应用研究进展[J].医学信息,2018,31(07):39.[doi:10.3969/j.issn.1006-1959.2018.07.014]
　WANG Wei-lin,ZHANG Jian.Progress in the Study of Hip and Knee Replacement in Tranexamic Acid[J].Medical Information,2018,31(21):39.[doi:10.3969/j.issn.1006-1959.2018.07.014]
[4]梁玉君,苏 茜.献血者差异性对红细胞质量影响的研究[J].医学信息,2018,31(09):63.[doi:10.3969/j.issn.1006-1959.2018.09.020]
　LIANG Yu-jun,SU Qian.Study on the Influence of Blood Donors' Differences on the Quality of Red Blood Cells[J].Medical Information,2018,31(21):63.[doi:10.3969/j.issn.1006-1959.2018.09.020]
[5]江 灵,王 华,王 静,等.RhCcEe抗原配合性输血在多次输血患者中的应用[J].医学信息,2022,35(09):168.[doi:10.3969/j.issn.1006-1959.2022.09.043]
　JIANG Ling,WANG Hua,WANG Jing,et al.Application of RhCcEe Compatibility Management in Blood Transfusion of Patients with Multiple Transfusions[J].Medical Information,2022,35(21):168.[doi:10.3969/j.issn.1006-1959.2022.09.043]
[6]张许林,余泽波.肝硬化上消化道出血的输血治疗进展[J].医学信息,2019,32(08):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
　ZHANG Xu-lin,YU Ze-bo.Progress in Transfusion Therapy for Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(21):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
[7]邓小春,蒋运兰,肖 力,等.使用线性蠕动机制输液泵输血安全性的Meta分析[J].医学信息,2020,33(07):82.[doi:10.3969/j.issn.1006-1959.2020.07.023]
　DENG Xiao-chun,JIANG Yun-lan,XIAO Li,et al.Meta-analysis of the Safety of Transfusion Pump Using Linear Peristaltic Mechanism[J].Medical Information,2020,33(21):82.[doi:10.3969/j.issn.1006-1959.2020.07.023]
[8]黄河龙,彭 莹,康怀应.六盘水地区不同民族住院患者红细胞血型及不规则抗体检测分析[J].医学信息,2023,36(15):79.[doi:10.3969/j.issn.1006-1959.2023.15.014]
　HUANG He-long,PENG Ying,KANG Huai-ying.Detection and Analysis of Red Blood Cell Blood Group and Irregular Antibody in Hospitalized Patients of Different Nationalities in Liupanshui Area[J].Medical Information,2023,36(21):79.[doi:10.3969/j.issn.1006-1959.2023.15.014]

更新日期/Last Update: 1900-01-01